Moderator: Dr. Carl Nathan
Thursday, August 20
5:00 - 6:00 p.m. (ET)
Infectious disease specialists on the front lines of the pandemic present the latest information on COVID-related clinical trials aimed at discovering new treatments and developing successful vaccines.
Meet the Speakers
Marshall Glesby, MD, PhD
Associate Chief, Division of Infectious Diseases
Professor of Healthcare Policy and Research
Dr. Glesby, who is also director of the Cornell HIV Clinical Trials Unit, is leading a clinical trial testing a drug designed to prevent the complications from COVID-19 that result when the body’s immune system goes into overdrive.
Roy Gulick, MD, MPH
Chief, Division of Infectious Diseases
Rochelle Belfer Professor in Medicine
Dr. Gulick is co-chair of the National Institutes of Health’s COVID-19 Treatment Guidelines Panel and is an internationally recognized leader in clinical research for infectious diseases and HIV.
Kristen Marks, MD
Associate Professor of Medicine
Dr. Marks is leading a multicenter clinical trial of remdesivir, an experimental drug designed to interfere with the COVID-19 virus’ ability to replicate in cells.
Carl Nathan, MD
Chairman, Department of Microbiology and Immunology
R.A. Rees Pritchett Professor of Microbiology
Dr. Nathan is one of the world’s leading authorities on tuberculosis and other infectious diseases, and advancing therapeutics from the bench to the bedside.
To learn more about Weill Cornell’s work in this area and the activities of our faculty, please visit these links:
- Learn more about Dr. Kristen Marks and her leading of the team conducting Moderna Therapeutics’ phase 3 COVID-19 vaccine trial. NewYork-Presbyterian/Weill Cornell Medical Center is one of dozens of medical centers around the U.S. where this still-experimental vaccine will be tested.
- Dr. Roy Gulick is co-chairing a National Institutes of Health panel that is developing treatment guidelines for COVID-19. Learn more about his and other Weill Cornell physician-scientists’ COVID research in the summer 2020 issue of Weill Cornell Medicine magazine.
- Dr. Carl Nathan, one of the world’s leading authorities on infectious diseases and advancing therapeutics from the bench to the bedside, is leading efforts to fight another looming health crisis: the rise of antibiotic-resistant infections.
- Dr. Marshall Glesby explains how clinical trials work in a fascinating article in The Cornell Daily Sun newspaper.
If you are interested in learning more about us or wish to support the important work that was presented by our faculty, please contact us at development@med.cornell.edu.